The global hemophilia treatment market is experiencing steady expansion, driven by advances in recombinant therapies, gene therapy developments, and increasing awareness of bleeding disorders. In 2021, the hemophilia treatment market size stood at US$ 14.44 billion and is projected to reach US$ 23.53 billion by 2031 , reflecting a strong growth trajectory over the forecast period. The market is...